AGP Picks
View all

Clinical trial equipment market seen reaching $4.09 billion by 2030

12 hours ago
Clinical trial equipment market seen reaching $4.09 billion by 2030
By AI, Created 00:30 UTC, Nov 19, 2026, AGP -

The clinical trial equipment and ancillary solutions market is projected to grow from $2.77 billion in 2025 to $4.09 billion by 2030, driven by more complex trials, rising chronic disease burden and greater healthcare spending. North America led in 2025, while Asia-Pacific is expected to grow fastest over the forecast period.

Why it matters: - The market supports the planning, management and execution of clinical research across therapeutic areas. - Growth in clinical trial equipment and ancillary solutions affects trial speed, compliance, monitoring and patient-centered study design. - The category is becoming more important as trials shift toward decentralized and hybrid models and require more digital support.

What happened: - The Business Research Company projected the global clinical trial equipment and ancillary solutions market will rise from $2.77 billion in 2025 to $3.02 billion in 2026. - The report forecast the market will reach $4.09 billion by 2030. - The report said the market will grow at a 7.9% CAGR from 2026 to 2030. - The company said the market grew in prior years because of more global clinical trials, expanded pharmaceutical research, higher outsourcing to contract research organizations, growth in medical device trials and wider use of standardized equipment. - The report identified North America as the largest regional market in 2025. - The report projected Asia-Pacific will be the fastest-growing region during the forecast period.

The details: - Clinical trial equipment and ancillary solutions include products, services and support frameworks used to conduct clinical research safely and efficiently. - The market is being shaped by decentralized and hybrid trials, real-time monitoring needs, digital health adoption, patient-centric trial designs and more complex regulatory requirements. - Key trends in the report include more clinical trial management system integration, greater use of remote and digital trial equipment, stronger ancillary logistics and support services, more decentralized trial solutions and more regulatory-compliant infrastructure. - Chronic disease prevalence is adding demand for trial support tools because long-term illnesses require ongoing research, monitoring and treatment development. - The Centers for Disease Control and Prevention reported in April 2025 that about 194 million U.S. adults, or 76.4%, had at least one chronic condition in 2023. - The CDC said chronic-condition prevalence in 2023 was 59.5% for young adults, 78.4% for midlife adults and 93.0% for older adults. - Rising healthcare spending is also boosting demand for clinical research infrastructure and support services. - The Centers for Medicare & Medicaid Services reported in December 2024 that U.S. healthcare expenditures rose 7.5% in 2023 to $4.9 trillion, or about $14,570 per person. - The report covered Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The company said its 2026 market reports now include market attractiveness scoring, TAM analysis, a company scoring matrix, Excel-based forecasting dashboards, market hotspots infographics, and updated graphics and tables. - The report offered a free sample through the sample request page. - The full report is available here.

Between the lines: - The forecast points to a market moving from basic trial support toward more technology-enabled infrastructure. - Faster growth in Asia-Pacific suggests clinical research expansion is broadening beyond the largest current market in North America. - The rising burden of chronic disease and higher healthcare spending both reinforce long-term demand for clinical trial tools and services.

What's next: - The market is expected to keep expanding through 2030 as decentralized trials, digital monitoring and regulatory demands increase. - Demand may continue shifting toward remote, compliant and data-rich trial systems. - More outsourcing to contract research organizations and more medical device trials are likely to remain important growth drivers.

The bottom line: - Clinical trial equipment and ancillary solutions are moving from a niche support category to a larger, faster-growing part of clinical research infrastructure.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

LATAM News Online

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

LATAM News Online

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.